Peter Nakaji
Overview
Explore the profile of Peter Nakaji including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
348
Citations
4226
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhao K, Barbagli G, Hussein A, Aglan O, Nakaji P
World Neurosurg
. 2024 Jun;
189:211.
PMID: 38906468
Colloid cysts are nonneoplastic epithelial lesions arising from the roof of the third ventricle near the foramen of Monro. They comprise approximately 0.5% to 2% of all brain lesions. Surgical...
2.
Wang L, Wang H, DAngelo F, Curtin L, Sereduk C, Leon G, et al.
PLoS One
. 2024 Apr;
19(4):e0299267.
PMID: 38568950
Background And Objective: Glioblastoma (GBM) is one of the most aggressive and lethal human cancers. Intra-tumoral genetic heterogeneity poses a significant challenge for treatment. Biopsy is invasive, which motivates the...
3.
Quiceno E, Seaman S, Hussein A, Delavari N, Prim M, Baaj A, et al.
Oper Neurosurg (Hagerstown)
. 2023 Nov;
PMID: 37976454
No abstract available.
4.
Quiceno E, Hussein A, Seaman S, Delavari N, Nakaji P
Oper Neurosurg (Hagerstown)
. 2023 Nov;
26(3):358.
PMID: 37934931
No abstract available.
5.
Hu L, DAngelo F, Weiskittel T, Caruso F, Fortin Ensign S, Blomquist M, et al.
Nat Commun
. 2023 Sep;
14(1):6066.
PMID: 37770427
Sampling restrictions have hindered the comprehensive study of invasive non-enhancing (NE) high-grade glioma (HGG) cell populations driving tumor progression. Here, we present an integrated multi-omic analysis of spatially matched molecular...
6.
Bond K, Curtin L, Hawkins-Daarud A, Urcuyo J, Leon G, Singleton K, et al.
medRxiv
. 2023 Jul;
PMID: 37503239
Background: Glioblastoma is an extraordinarily heterogeneous tumor, yet the current treatment paradigm is a "one size fits all" approach. Hundreds of glioblastoma clinical trials have been deemed failures because they...
7.
Nakaji P, Bozinov O
Neurosurg Clin N Am
. 2023 Mar;
34(2):xi-xii.
PMID: 36906337
No abstract available.
8.
Nosova K, Quiceno E, Hussein A, Bozinov O, Nakaji P
Neurosurg Clin N Am
. 2023 Mar;
34(2):193-198.
PMID: 36906326
Laser interstitial thermal therapy (LITT) and high-intensity focused ultrasound thermal ablation are treatment options with great potential to treat glioblastoma, metastasis, epilepsy, essential tremor, and chronic pain. Results from recent...
9.
Smith K, Nakaji P, Thomas T, Pinnaduwage D, Wallstrom G, Choi M, et al.
Neuro Oncol
. 2022 Nov;
24(Suppl 6):S4-S15.
PMID: 36322102
Background: Treatment of recurrent glioblastoma (GBM) remains problematic with survival after additional therapy typically less than 12 months. We prospectively evaluated whether outcomes might be improved with resection plus permanent...
10.
Nisson P, Wicks R, Zhao X, James W, Xu D, Nakaji P
Neurosurg Focus Video
. 2022 Oct;
1(1):V26.
PMID: 36285066
Cavernous malformations of the brain are low-flow vascular lesions that have a propensity to hemorrhage. Extensive surgical approaches are often required for operative cure of deep-seated lesions. A 23-year-old female...